123 related articles for article (PubMed ID: 27355833)
1. Antibacterial and Solubility Optimization of Thiomuracin A.
LaMarche MJ; Leeds JA; Brewer J; Dean K; Ding J; Dzink-Fox J; Gamber G; Jain A; Kerrigan R; Krastel P; Lee K; Lombardo F; McKenney D; Neckermann G; Osborne C; Palestrant D; Patane MA; Rann EM; Robinson Z; Schmitt E; Stams T; Tiamfook S; Yu D; Whitehead L
J Med Chem; 2016 Jul; 59(14):6920-8. PubMed ID: 27355833
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic optimization and chemical structure stabilization of thiomuracin A.
LaMarche MJ; Leeds JA; Dzink-Fox J; Gangl E; Krastel P; Neckermann G; Palestrant D; Patane MA; Rann EM; Tiamfook S; Yu D
J Med Chem; 2012 Aug; 55(15):6934-41. PubMed ID: 22812377
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial optimization of 4-aminothiazolyl analogues of the natural product GE2270 A: identification of the cycloalkylcarboxylic acids.
LaMarche MJ; Leeds JA; Amaral K; Brewer JT; Bushell SM; Dewhurst JM; Dzink-Fox J; Gangl E; Goldovitz J; Jain A; Mullin S; Neckermann G; Osborne C; Palestrant D; Patane MA; Rann EM; Sachdeva M; Shao J; Tiamfook S; Whitehead L; Yu D
J Med Chem; 2011 Dec; 54(23):8099-109. PubMed ID: 21999529
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs.
Xu L; Farthing AK; Dropinski JF; Meinke PT; McCallum C; Hickey E; Liu K
Bioorg Med Chem Lett; 2013 Jan; 23(1):366-9. PubMed ID: 23164707
[TBL] [Abstract][Full Text] [Related]
5. 4-Aminothiazolyl analogues of GE2270 A: antibacterial lead finding.
LaMarche MJ; Leeds JA; Dzink-Fox J; Gunderson K; Krastel P; Memmert K; Patane MA; Rann EM; Schmitt E; Tiamfook S; Wang B
J Med Chem; 2011 Apr; 54(7):2517-21. PubMed ID: 21405087
[TBL] [Abstract][Full Text] [Related]
6. Discovery of LFF571: an investigational agent for Clostridium difficile infection.
LaMarche MJ; Leeds JA; Amaral A; Brewer JT; Bushell SM; Deng G; Dewhurst JM; Ding J; Dzink-Fox J; Gamber G; Jain A; Lee K; Lee L; Lister T; McKenney D; Mullin S; Osborne C; Palestrant D; Patane MA; Rann EM; Sachdeva M; Shao J; Tiamfook S; Trzasko A; Whitehead L; Yifru A; Yu D; Yan W; Zhu Q
J Med Chem; 2012 Mar; 55(5):2376-87. PubMed ID: 22315981
[TBL] [Abstract][Full Text] [Related]
7. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model.
Tague AJ; Putsathit P; Hutton ML; Hammer KA; Wales SM; Knight DR; Riley TV; Lyras D; Keller PA; Pyne SG
Eur J Med Chem; 2019 May; 170():203-224. PubMed ID: 30901686
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure activity relationship (QSAR) studies on nitazoxanide-based analogues against Clostridium difficile In vitro.
Zhang H; Liu X; Yang Y; Li J
Pak J Pharm Sci; 2016 Sep; 29(5):1681-1689. PubMed ID: 27731829
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives.
Zhang SJ; Yang Q; Xu L; Chang J; Sun X
Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891
[TBL] [Abstract][Full Text] [Related]
10. 4-Aminothiazolyl analogs of GE2270 A: design, synthesis and evaluation of imidazole analogs.
LaMarche MJ; Leeds JA; Dzink-Fox J; Mullin S; Patane MA; Rann EM; Tiamfook S
Bioorg Med Chem Lett; 2011 Jun; 21(11):3210-5. PubMed ID: 21550238
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.
Yin N; Li J; He Y; Herradura P; Pearson A; Mesleh MF; Mascio CT; Howland K; Steenbergen J; Thorne GM; Citron D; Van Praagh AD; Mortin LI; Keith D; Silverman J; Metcalf C
J Med Chem; 2015 Jun; 58(12):5137-42. PubMed ID: 25993059
[TBL] [Abstract][Full Text] [Related]
12. Facilely accessible quinoline derivatives as potent antibacterial agents.
Teng P; Li C; Peng Z; Anne Marie V; Nimmagadda A; Su M; Li Y; Sun X; Cai J
Bioorg Med Chem; 2018 Jul; 26(12):3573-3579. PubMed ID: 29858158
[TBL] [Abstract][Full Text] [Related]
13. Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.
Li C; Teng P; Peng Z; Sang P; Sun X; Cai J
ChemMedChem; 2018 Jul; 13(14):1414-1420. PubMed ID: 29768720
[TBL] [Abstract][Full Text] [Related]
14. Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis.
Singh SB; Xu L; Meinke PT; Kurepina N; Kreiswirth BN; Olsen DB; Young K
J Antibiot (Tokyo); 2017 May; 70(5):671-674. PubMed ID: 28096545
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the structure of thiopeptides: assessment of thiazoline and tail moieties of baringolin and antibacterial activity optimization.
Just-Baringo X; Bruno P; Pitart C; Vila J; Albericio F; Álvarez M
J Med Chem; 2014 May; 57(10):4185-95. PubMed ID: 24738558
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis and antifungal evaluation of cyclic aminohexapeptides.
Klein LL; Li L; Chen HJ; Curty CB; DeGoey DA; Grampovnik DJ; Leone CL; Thomas SA; Yeung CM; Funk KW; Kishore V; Lundell EO; Wodka D; Meulbroek JA; Alder JD; Nilius AM; Lartey PA; Plattner JJ
Bioorg Med Chem; 2000 Jul; 8(7):1677-96. PubMed ID: 10976515
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications.
Clough J; Chen S; Gordon EM; Hackbarth C; Lam S; Trias J; White RJ; Candiani G; Donadio S; Romanò G; Ciabatti R; Jacobs JW
Bioorg Med Chem Lett; 2003 Oct; 13(20):3409-14. PubMed ID: 14505638
[TBL] [Abstract][Full Text] [Related]
18. Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).
Basarab GS; Hill PJ; Garner CE; Hull K; Green O; Sherer BA; Dangel PB; Manchester JI; Bist S; Hauck S; Zhou F; Uria-Nickelsen M; Illingworth R; Alm R; Rooney M; Eakin AE
J Med Chem; 2014 Jul; 57(14):6060-82. PubMed ID: 24959892
[TBL] [Abstract][Full Text] [Related]
19. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
[TBL] [Abstract][Full Text] [Related]
20. Modifying the lipophilic part of phenylthiazole antibiotics to control their drug-likeness.
Hosny Y; Abutaleb NS; Omara M; Alhashimi M; Elsebaei MM; Elzahabi HS; Seleem MN; Mayhoub AS
Eur J Med Chem; 2020 Jan; 185():111830. PubMed ID: 31718945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
